Henderson Group »

Lb Pharmaceuticals shares owned by Henderson Group

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 65k 24.66

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Trails Edge Capital Partners
Vanguard Group
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Vanguard Capital Management
Alyeska Investment Group
Vivo Capital
Jennison Associates
Geode Capital Management

View all funds holding Lb Pharmaceuticals